The anti-thrombin III testing market was valued at USD 159.30 Million in 2025 and is expected to grow at a CAGR of 6.20%, reaching USD 290.71 Million by 2035. The market growth is driven by rising incidence of thrombotic disorders and demand for precise diagnostic tests.
Base Year
Historical Period
Forecast Period
The market for anti-thrombin III testing is experiencing significant growth due to the rising incidence of thrombotic disorders like deep vein thrombosis (DVT), and pulmonary embolism (PE), among others.
In the forecast period, North America is projected to hold a significant market share, which can be attributed to the presence of a well-established healthcare and research infrastructure in the region.
The market value is poised to be driven by continuous research activities, focused on developing new diagnostic solutions in the domain.
Compound Annual Growth Rate
6.2%
Value in USD Million
2026-2035
*this image is indicative*
Antithrombin III, simply recognised as antithrombin is a protein in the blood that helps manage blood clotting by inhibiting certain enzymes involved in the coagulation process. It is a natural anticoagulant that prevents excessive clotting and helps in balancing the ability of blood to clot and flow freely.
The anti-thrombin deficiency symptoms are similar to the manifestations of other conditions such as antiphospholipid syndrome, deficiency of protein S, and deficiency of protein C. The rising incidence of deficiency-associated illnesses makes it important to have effective anti-thrombin III test kits and systems for hospitals and testing centres. Exact test results can enable medical practitioners to administer reliable treatments for the condition of the patient. As a result, the market value for test kits and devices for anti-thrombin III has increased in recent years. Additionally, a shift towards rapid diagnosis and the emergence of multiple blood clotting disorders will also have a positive impact on the growth of the market.
Increasing Incidence of Thrombotic Disorders Boost Market Growth
According to the data released by the US Centers for Disease Control and Prevention, nearly 900,000 people are estimated to be affected by venous thromboembolism (VTE) each year in the United States. Additionally, the estimated number of total deaths in the U.S. due to venous thromboembolism (VTE) has been estimated to be around 60,000-100,000 people annually. The rising incidence of blood clots and related issues is expected to boost the market growth for anti-thrombin III testing in the forecast period.
Surge in Research Activities to Meet the Rising Anti-Thrombin III Testing Market Demand
In 2023, a research project funded by the European Union’s Horizon 2020 Research and Innovation program successfully developed a mass spectrometry-based test to characterise different molecular forms of antithrombin. This test is anticipated to bring precision to the anti-thrombin III testing as it can be used to explore the clinical relevance of specific antithrombin proteoforms, especially in cases where traditional tests generate ambiguous results. It will generate accurate diagnoses and support medical approaches to develop personalised treatments, propelling the market demand. This also marks a significant milestone in the development of advanced diagnostic tools. Healthcare providers can now adopt new technologies and curb the demand for innovative diagnostic solutions. This innovative diagnostic solution is expected to generate a market demand for more innovations and increase the market value in the forecast period.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
“Anti-Thrombin III Testing Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Anti-Thrombin III Testing Based on Product to Lead the Market Share
The market segment by product is divided into instruments, kits and reagents among others. In the forecast period, the instruments section is estimated to undergo rapid growth, which can be accredited to the advent of new products into the market. Several companies are developing instruments, enabled with automation and precision diagnostics so as to facilitate ease in workflow, efficiency and convenience. On the other hand, kits and reagents hold a substantial market share as healthcare professionals rely on ready-to-use alternatives for immediate testing.
Anti-Thrombin III Testing Market Analysis by Region
Based on region, the market is divided into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. North America is significantly dominating the market. The region is leading due to its high-tech healthcare infrastructure integrated with advanced technologies and world-class facilities. It is also witnessing a relatively high prevalence of conditions associated with blood clotting disorders, such as deep vein thrombosis, contributing to the increasing demand for comprehensive diagnostic testing, supporting the dominance of the region.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Commonly known as Roche, it is a Swiss multinational healthcare company operating in pharmaceuticals and diagnostics. It is the fifth-largest pharmaceutical company in the world by revenue specialising in providing treatments for cancer globally.
It is a German multinational company focused on providing innovative healthcare solutions through advanced technologies and services. The company offers a comprehensive range of diagnostic solutions, including clinical chemistry, immunoassays, hematology, and molecular diagnostics.
It is an American multinational company that develops and sells medical devices and healthcare products. The company is a global leader in diagnostic solutions and offers advanced laboratory systems and point-of-care testing products. Their diagnostics division includes immunoassays, clinical chemistry, hematology, and molecular diagnostics.
It is a Danaher Corporation company focused on developing, manufacturing, and marketing laboratory instruments and reagents used in biomedical testing. Their product portfolio includes immunoassay systems, hematology analyzers, clinical chemistry analyzers, and automation solutions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sysmex Corporation, Horiba Abx SAS, bioMerieux SA, and HemoSonics, LLC, among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share